RE:RE:RE:RE:RE:The reality boazklinghorn wrote: Also dont forget that we burned 1.3 Million cash last quarter. It wasnt just a loss quarter it was a BIG loss.
In its Year-End Financials CZO had recognized a defered tax liability of $1,095,986. Are you suggesting it shouldn't have paid taxes?
Given the significant expenses CZO expects this year would you rather CZO report revenue this year as opposed to last year to minimize the tax bill this year? CZO built record inventory in Q4 helping reduce profit and added significant inventory in Q1 2023 too. With record inventory on hand and re-ordering expected to commence with the completion of the Aveeno and Neutrogena spin-out could CZO have a sigificant revenue surge in future quarters as it also has the surge in avenanthramide clinical trial costs, etc.? Could there be tax planning involved?